ClinicalTrials.Veeva

Menu

Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis

U

University of Wuerzburg

Status

Completed

Conditions

Adrenal Insufficiency
Hashimoto Disease

Treatments

Drug: synacthen

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether patients with Hashimoto thyroiditis and impaired well-being may have a partial secondary adrenocortical insufficiency.

Full description

Many patients with Hashimoto thyroiditis who are correctly substituted with thyroid hormones have an impaired well-being. in some people an isolated ACTH deficiency was found.

In this study a 1 µg ACTH test is performed to evaluate the adrenocortical function.

Enrollment

62 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Hashimoto thyroiditis euthyreot thyroid function with levothyroxin therapy written informed consent

Exclusion criteria

  • • hypothyroidism of other origin

    • pregnancy and lactation
    • oral contraception
    • glucocorticoid therapy during the last 2 months
    • History of malignancy or chronic infections (Hepatitis, HIV)

Trial design

62 participants in 4 patient groups

1
Other group
Description:
healthy people without Hashimoto disease receive a 1µg ACTH stimulation test
Treatment:
Drug: synacthen
2
Other group
Description:
patients with Hashimoto disease with well being receive a 1 µg ACTH stimulation test
Treatment:
Drug: synacthen
3
Other group
Description:
patients with Hashimoto disease an impaired well-being receive a 1 µg ACTH stimulation test
Treatment:
Drug: synacthen
4
Other group
Description:
patients with Hashimoto disease and negative TPO antibodies receive a 1µg ACTH stimulation test
Treatment:
Drug: synacthen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems